123 related articles for article (PubMed ID: 962443)
1. Hypertension and renal disease in systemic lupus erythematosus.
Budman DR; Steinberg AD
Arch Intern Med; 1976 Sep; 136(9):1003-7. PubMed ID: 962443
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
4. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
Barnett EV; Dornfeld L; Lee DB; Liebling MR
J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
[TBL] [Abstract][Full Text] [Related]
5. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
6. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
7. Hypertension increases the risk of renal deterioration in systemic lupus erythematosus.
Ginzler EM; Felson DT; Anthony JM; Anderson JJ
J Rheumatol; 1993 Oct; 20(10):1694-700. PubMed ID: 8295180
[TBL] [Abstract][Full Text] [Related]
8. Tubulointerstitial renal disease in systemic lupus erythematosus.
O'Dell JR; Hays RC; Guggenheim SJ; Steigerwald JC
Arch Intern Med; 1985 Nov; 145(11):1996-9. PubMed ID: 4062450
[TBL] [Abstract][Full Text] [Related]
9. Glomerular podocytopathy in patients with systemic lupus erythematosus.
Kraft SW; Schwartz MM; Korbet SM; Lewis EJ
J Am Soc Nephrol; 2005 Jan; 16(1):175-9. PubMed ID: 15548564
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
11. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
12. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
[TBL] [Abstract][Full Text] [Related]
13. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus.
Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Bush AJ; Wan JY
Am J Obstet Gynecol; 2005 Nov; 193(5):1676-9. PubMed ID: 16260209
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
[TBL] [Abstract][Full Text] [Related]
15. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up on the treatment of diffuse proliferative glomerulonephritis in patients with systemic lupus erythematosus].
Golan E; Weintal I; Bernheim J; Ben-Chetrit S; Bernheim J
Harefuah; 2002 Apr; 141(4):324-8, 412. PubMed ID: 12017882
[TBL] [Abstract][Full Text] [Related]
17. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
[TBL] [Abstract][Full Text] [Related]
18. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of clearance studies in lupus nephritis.
Rosenbaum JL; Akhtar M; Kramer MS; Raja RM; Manchanda R; Lazaro N
Clin Nephrol; 1974; 2(2):47-51. PubMed ID: 4830511
[No Abstract] [Full Text] [Related]
20. Isolated pyuria in systemic lupus erythematosus.
Appenzeller S; Clark A; Pineau C; Vasilevsky M; Bernatsky S
Lupus; 2010 Jun; 19(7):793-6. PubMed ID: 20305045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
